Naar www.iknl.nl
- Dermatologie > Basaalcelcarcinoom
Notificatie richtlijn E-mail richtlijn Naar startpagina oncoline
----------

Laatst gewijzigd : 2015-10-16, Versie: 2.1, Verantwoording: Nederlandse Vereniging voor Dermatologie en Venereologie, Type: Landelijke richtlijn

Referentielijst

1 - Alessi SS (2009)

Alessi SS, Sanches JA, Oliveira WR, Messina MC, Pimentel ER, and Festa NC. Treatment of cutaneous tumors with topical 5% imiquimod cream. Clinics (Sao Paulo, Brazil) 64:961-6. 2009. Clinics.Festa NC. Clinics (Sao Paulo). # http://www.ncbi.nlm.nih.gov/pubmed/19841702

 
2 - Arits AH (2013)

Arits AH, Mosterd K, Essers BA, Spoorenberg E, Sommer A, De Rooij MJ, van Pelt HP, Quaedvlieg, PJ, Krekels GA, van Neer PA, Rijzewijk JJ, van Geest AJ, Steijlen PM, Nelemans PJ, andKelleners-Smeets NW. 2013. Photodynamic therapy versus topical imiquimod versus topica fluorouracil for treatment of superficial basal-cell carcinoma: A single blind, non-inferiority, randomised controlled trial. Lancet Oncology. # http://www.ncbi.nlm.nih.gov/pubmed/23683751

 
3 - Arits AH (2011)

Arits AH, Schlangen MH, Nelemans PJ, and Kelleners-Smeets NW. Trends in the incidence of basal cell carcinoma by histopathological subtype. J. Eur. Acad. Dermatol. Venereol. 2011; 25 (5): 565-569. # http://www.ncbi.nlm.nih.gov/pubmed/20840348

 
4 - Arits AH (2014)

Arits AH, Spoorenberg E, Mosterd K, Nelemans P, Kelleners-Smeets NW, Essers BA. Cost-effectiveness of topical imiquimod and fluorouracil versus photodynamic therapy for treatment of superficial basal-cell carcinoma. Br J Dermatol 2014 Dec;171(6):1501-7 # http://www.ncbi.nlm.nih.gov/pubmed/24749843

 
5 - Avril MF (1997)

Avril MF, Auperin A, Margulis A, Gerbaulet A, Duvillard P, Benhamou E, et al. Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomized study. Br J Cancer 1997;76(1):100-6. # http://www.ncbi.nlm.nih.gov/pubmed/9218740

 
6 - Baptista J (2006)

Baptista J, Martinez C, Leite L, Cochito M. Our PDT experience in the treatment of non-melanoma skin cancer over the last 7 years. J Eur Acad Dermatol Venereol 2006 Jul;20(6):693-7. # http://www.ncbi.nlm.nih.gov/pubmed/16836497

 
7 - Basset-Seguin N (2001)
Basset-Seguin N, Ibbotson S, Emtestam L. Photodynamic therapy using Metvix© is as efficacious as cryotherapy in BCC, with better cosmetic results. J Eur Acad Dermatol Venereol 2001; 15 Suppl. 2:
 
8 - Basset-Seguin N (2008)

Basset-Seguin N, Ibbotson SH, Emtestam L, Tarstedt M, Morton C, Maroti M, et al. Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma: a 5 year randomized trial. Eur J Dermatol 2008 Sep;18(5):547-53. # http://www.ncbi.nlm.nih.gov/pubmed/18693158

 
9 - Bath-Hextall F (2004)

Bath-Hextall F, Bong J, Perkins W, Williams H. Interventions for basal cell carcinoma of the skin: systematic review. BMJ 2004 Sep 25;329(7468):705. # http://www.ncbi.nlm.nih.gov/pubmed/15364703

 
10 - Bath-Hextall F (2014)

Bath-Hextall F, Ozolins M, Armstrong SJ, Colver GB, Perkins W, Miller PS, and Williams HC. Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial. The lancet oncology 2014.15:96-105. Lancet Oncology. # http://www.ncbi.nlm.nih.gov/pubmed/24332516

 
11 - Berlin J (2002)

Berlin J, Katz KH, Helm KF, Maloney ME. The significance of tumor persistence after incomplete excision of basal cell carcinoma. J Am Acad Dermatol 2002 Apr;46(4):549-53. # http://www.ncbi.nlm.nih.gov/pubmed/11907506

 
12 - Bessems P (1989)
Bessems P. The cryosurgical open-cone-spray method [proefschrift]. Maastricht; 1989.
 
13 - Beutner KR (1999)

Beutner KR, Geisse JK, Helman D, Fox TL, Ginkel A, Owens ML. Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream. J Am Acad Dermatol 1999 Dec;41(6):1002-7. # http://www.ncbi.nlm.nih.gov/pubmed/10570388

 
14 - Bieley HC (1992)

Bieley HC, Kirsner RS, Reyes BA, Garland LD. The use of Mohs micrographic surgery for determination of residual tumor in incompletely excised basal cell carcinoma. J Am Acad Dermatol 1992 May;26(5 Pt 1):754-6. # http://www.ncbi.nlm.nih.gov/pubmed/1583176

 
15 - Breuninger H (1991)

Breuninger H, Dietz K. Prediction of subclinical tumor infiltration in basal cell carcinoma. J Dermatol Surg Oncol 1991 Jul;17(7):574-8. # http://www.ncbi.nlm.nih.gov/pubmed/1860987

 
16 - Caccialanza M (2001)

Caccialanza M, Piccinno R, Grammatica A. Radiotherapy of recurrent basal and squamous cell skin carcinomas: a study of 249 re-treated carcinomas in 229 patients. Eur J Dermatol 2001 Jan;11(1):25-8. # http://www.ncbi.nlm.nih.gov/pubmed/11174133

 
17 - Cairnduff F (1994)

Cairnduff F, Stringer MR, Hudson EJ, Ash DV, Brown SB. Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer. Br J Cancer 1994 Mar;69(3):605-8. # http://www.ncbi.nlm.nih.gov/pubmed/8123497

 
18 - Castano AP (2006)

Castano AP, Mroz P, Hamblin MR. Photodynamic therapy and anti-tumour immunity. Nat Rev Cancer 2006 Jul;6(7):535-45. # http://www.ncbi.nlm.nih.gov/pubmed/16794636

 
19 - Chang AL (2014)

Chang AL, Solomon JA, Hainsworth JD, Goldberg L, McKenna E, Day BM, et al. Expanded access study of patients with advanced basal cell carcinoma treated with the Hedgehog pathway inhibitor, vismodegib. Journal of the American Academy of Dermatology 2014; 70:60-9. # http://www.ncbi.nlm.nih.gov/pubmed/24189279

 
20 - Dijkstra AT (2001)

Dijkstra AT, Majoie IM, van Dongen JW, van WH, van Vloten WA. Photodynamic therapy with violet light and topical 6-aminolaevulinic acid in the treatment of actinic keratosis, Bowen's disease and basal cell carcinoma. J Eur Acad Dermatol Venereol 2001 Nov;15(6):550-4. # http://www.ncbi.nlm.nih.gov/pubmed/11843215

 
21 - Dreier J (2013)

Dreier J, Felderer L, Barysch M, Rozati S, Dummer R (2013) Basal cell carcinoma: a paradigm for targeted therapies. Expert opinion on pharmacotherapy 14:1307-18. # http://www.ncbi.nlm.nih.gov/pubmed/23656611

 
22 - Epstein EH (2008)

Epstein EH. Basal cell carcinomas: attack of the hedgehog. Nat Rev Cancer 2008 Oct;8(10):743-54. # http://www.ncbi.nlm.nih.gov/pubmed/18813320

 
23 - Euvrard S (2003)

Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003 Apr 24;348(17):1681-91. # http://www.ncbi.nlm.nih.gov/pubmed/12711744

 
24 - Ezughah FI (2008)

Ezughah FI, Dawe RS, Ibbotson SH, Fleming CJ. A randomized parallel study to assess the safety and efficacy of two different dosing regimens of 5% imiquimod in the treatment of superficial basal cell carcinoma. J Dermatolog Treat 2008;19(2):111-7. # http://www.ncbi.nlm.nih.gov/pubmed/17917935

 
25 - Flohil SC-a (2013)

Flohil 2013a: Flohil SC, Seubring I, van Rossum MM, Coebergh JW, de Vries E, and Nijsten T. 2013. Trends in Basal cell carcinoma incidence rates: a 37-year Dutch observational study. J. Invest Dermatol. 133 (4): 913-918.[2013a] # http://www.ncbi.nlm.nih.gov/pubmed/23190883

 
26 - Flohil SC-b (2013)

Flohil 2013b: Flohil SC, van Tiel S, Koljenovic S, Jaanen-van der Sanden G, Overbeek LI, de Vries E, and Nijsten T. 2013. Frequency of non-histologically diagnosed basal cell carcinomas in daily Dutch practice. J. Eur. Acad. Dermatol. Venereol. 27 (7): 907-911. [2013b] # http://www.ncbi.nlm.nih.gov/pubmed/22211725

 
27 - Flohil SC-a (2011)

Flohil SC, de Vries E, Neumann HA, Coebergh JW, and Nijsten T. 2011. Incidence, prevalence and future trends of primary basal cell carcinoma in the Netherlands. Acta Derm. Venereol. 91 (1): 24-30. # http://www.ncbi.nlm.nih.gov/pubmed/21264452

 
28 - Flohil SC-b (2011)

Flohil SC, Koljenovic S, de Haas ER, Overbeek LI, de Vries E, and Nijsten T. 2011. Cumulative risks and rates of subsequent basal cell carcinomas in the Netherlands. Br. J. Dermatol. 165 (4): 874-881. [2011b] # http://www.ncbi.nlm.nih.gov/pubmed/21711333

 
29 - Flohil SC-c (2013)

Flohil SC, van der Leest RJ, Arends LR, de Vries E, and Nijsten T. 2013. Risk of subsequent cutaneous malignancy in patients with prior keratinocyte carcinoma: a systematic review and meta-analysis. Eur. J. Cancer 49 (10): 2365-2375. [2013c] # http://www.ncbi.nlm.nih.gov/pubmed/23608733

 
30 - Geisse J (2004)

Geisse J, Caro I, Lindholm J, Golitz L, Stampone P, Owens M. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies. J Am Acad Dermatol 2004 May;50(5):722-33. # http://www.ncbi.nlm.nih.gov/pubmed/15097956

 
31 - Geisse JK (2002)

Geisse JK, Rich P, Pandya A, Gross K, Andres K, Ginkel A, et al. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: a double-blind, randomized, vehicle-controlled study. J Am Acad Dermatol 2002 Sep;47(3):390-8. # http://www.ncbi.nlm.nih.gov/pubmed/12196749

 
32 - Gollnick H (2008)

Gollnick H, Barona CG, Frank RG, Ruzicka T, Megahed M, Maus J, et al. Recurrence rate of superficial basal cell carcinoma following treatment with imiquimod 5% cream: conclusion of a 5-year long-term follow-up study in Europe. Eur J Dermatol 2008 Nov;18(6):677-82. # http://www.ncbi.nlm.nih.gov/pubmed/18955210

 
33 - Gollnick H (2005)

Gollnick H, Barona CG, Frank RG, Ruzicka T, Megahed M, Tebbs V, et al. Recurrence rate of superficial basal cell carcinoma following successful treatment with imiquimod 5% cream: interim 2-year results from an ongoing 5-year follow-up study in Europe. Eur J Dermatol 2005 Sep;15(5):374-81. # http://www.ncbi.nlm.nih.gov/pubmed/16172048

 
34 - Gooding CA (1965)

Gooding CA, White G, Yatsuhashi M. Significance of marginal extension in excised basal-cell carcinoma. N Engl J Med 1965 Oct 21;273(17):923-4. # http://www.ncbi.nlm.nih.gov/pubmed/5832875

 
35 - Graham GF (1990)

Graham GF, Clark LC. Statistical analysis in cryosurgery of skin cancer. Clin Dermatol 1990 Jan;8(1):101-7. # http://www.ncbi.nlm.nih.gov/pubmed/2393839

 
36 - Gross K (2007)

Gross K, Kircik L, Kricorian G. 5% 5-Fluorouracil cream for the treatment of small superficial Basal cell carcinoma: efficacy, tolerability, cosmetic outcome, and patient satisfaction. Dermatol Surg 2007 Apr;33(4):433-9. # http://www.ncbi.nlm.nih.gov/pubmed/17430377

 
37 - Guix B (2000)

Guix B, Finestres F, Tello J, Palma C, Martinez A, Guix J, et al. Treatment of skin carcinomas of the face by high-dose-rate brachytherapy and custom-made surface molds. Int J Radiat Oncol Biol Phys 2000 Apr 1;47(1):95-102. # http://www.ncbi.nlm.nih.gov/pubmed/10758310

 
38 - Haas de ER (2006)

Haas de ER, Kruijt B, Sterenborg HJ, Martino Neumann HA, Robinson DJ. Fractionated illumination significantly improves the response of superficial basal cell carcinoma to aminolevulinic acid photodynamic therapy. J Invest Dermatol 2006 Dec;126(12):2679-86. # http://www.ncbi.nlm.nih.gov/pubmed/16841035

 
39 - Hall VL (1986)

Hall VL, Leppard BJ, McGill J, Kesseler ME, White JE, Goodwin P. Treatment of basal-cell carcinoma: comparison of radiotherapy and cryotherapy. Clin Radiol 1986 Jan;37(1):33-4. # http://www.ncbi.nlm.nih.gov/pubmed/3514075

 
40 - Haller JC (2000)

Haller JC, Cairnduff F, Slack G, Schofield J, Whitehurst C, Tunstall R, et al. Routine double treatments of superficial basal cell carcinomas using aminolaevulinic acid-based photodynamic therapy. Br J Dermatol 2000 Dec;143(6):1270-5. # http://www.ncbi.nlm.nih.gov/pubmed/11122032

 
41 - Hauben DJ (1982)

Hauben DJ, Zirkin H, Mahler D, Sacks M. The biologic behavior of basal cell carcinoma: Part I. Plast Reconstr Surg 1982 Jan;69 (1):103-9. # http://www.ncbi.nlm.nih.gov/pubmed/7053497

 
42 - Hauschild A (2008)

Hauschild A, Breuninger H, Kaufmann R, Kortmann RD, Schwipper V, Werner J, et al. Short German guidelines: basal cell carcinoma. J Dtsch Dermatol Ges 2008 May;6 Suppl 1:S2-S4. # http://www.ncbi.nlm.nih.gov/pubmed/18801139

 
43 - Holterhues C (2010)

Holterhues C, de Vries E, Louwman MW, Koljenovic S, and Nijsten T. 2010. Incidence and trends of cutaneous malignancies in the Netherlands, 1989-2005. J. Invest Dermatol. 130 (7): 1807-1812. # http://www.ncbi.nlm.nih.gov/pubmed/20336085

 
44 - Hurlimann AF (1998)

Hurlimann AF, Hanggi G, Panizzon RG. Photodynamic therapy of superficial basal cell carcinomas using topical 5-aminolevulinic acid in a nanocolloid lotion. Dermatology 1998;197(3):248-54. # http://www.ncbi.nlm.nih.gov/pubmed/9812030

 
45 - Iersel van CA (2005)

Iersel van CA, van de Velden HV, Kusters CD, Spauwen PH, Blokx WA, Kiemeney LA, and Gerritsen MJ. 2005. Prognostic factors for a subsequent basal cell carcinoma: implications for follow-up. Br. J. Dermatol. 153 (5): 1078-1080. # http://www.ncbi.nlm.nih.gov/pubmed/16225637

 
46 - Kiiski V (2010)

Kiiski V, de Vries E, Flohil SC, Bijl MJ, Hofman A, Stricker BH, and Nijsten T. 2010. Risk factors for single and multiple basal cell carcinomas. Arch. Dermatol. 146 (8): 848-855. # http://www.ncbi.nlm.nih.gov/pubmed/20713815

 
47 - Kopf AW (1977)

Kopf AW, Bart RS, Schrager D, Lazar M, Popkin GL. Curettage-electrodesiccation treatment of basal cell carcinomas. Arch Dermatol 1977 Apr;113(4):439-43. # http://www.ncbi.nlm.nih.gov/pubmed/848972

 
48 - Koplin L (1980)

Koplin L, Zarem HA. Recurrent basal cell carcinoma. A review concerning the incidence, behavior, and management of recurrent basal cell carcinoma, with emphasis on the incompletely excised lesion. Plast Reconstr Surg 1980 May;65(5):656-64. # http://www.ncbi.nlm.nih.gov/pubmed/7367506

 
49 - Krekels PJ. GA (2013)

Krekels PJ. GA, van Neer PA, Rijzewijk JJ, van Geest AJ, Steijlen PM, Nelemans PJ, and Kelleners-Smeets NW. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: A single blind, non-inferiority, randomised controlled trial. Lancet Oncology 2013 Jun;14(7):647-54. # http://www.ncbi.nlm.nih.gov/pubmed/23683751

 
50 - Kuflik EG (2004)

Kuflik EG. Cryosurgery for skin cancer: 30-year experience and cure rates. Dermatol Surg 2004 Feb;30(2 Pt 2):297-300. # http://www.ncbi.nlm.nih.gov/pubmed/14871224

 
51 - Landthaler M (1995)

Landthaler M, Hagspiel HJ, Braun-Falco O. Late irradiation damage to the skin caused by soft X-ray radiation therapy of cutaneous tumors. Arch Dermatol 1995 Feb;131(2):182-6. # http://www.ncbi.nlm.nih.gov/pubmed/7857115

 
52 - Langmack K (2001)
Langmack K, Mehta R, Twyman P, Norris P. Topical photodynamic therapy at low fluence rates--theory and practice. Journal of photochemistry and photobiology B, Biology 2001;60:37-43
 
53 - Launis J (1993)
Launis J. Curettage for treatment of non-melanoma skin cancer [abstract]. Melanoma Research 1993; 3:27."
 
54 - Lindgren G (1997)

Lindgren G, Larko O. Long-term follow-up of cryosurgery of basal cell carcinoma of the eyelid. J Am Acad Dermatol 1997 May;36 (5 Pt 1):742-6. # http://www.ncbi.nlm.nih.gov/pubmed/9146537

 
55 - Liu FF (1991)

Liu FF, Maki E, Warde P, Payne D, Fitzpatrick P. A management approach to incompletely excised basal cell carcinomas of skin. Int J Radiat Oncol Biol Phys 1991 Mar;20(3):423-8. # http://www.ncbi.nlm.nih.gov/pubmed/1899855

 
56 - Lo JS (1991)

Lo JS, Snow SN, Reizner GT, Mohs FE, Larson PO, Hruza GJ. Metastatic basal cell carcinoma: report of twelve cases with a review of the literature. J Am Acad Dermatol 1991 May;24(5 Pt 1):715-9. # http://www.ncbi.nlm.nih.gov/pubmed/1869642

 
57 - Sekulic A (2013)
Sekulic A; Migden MR; Basset-Seguin N; Garbe C; Gesierich A; Lao CD; Miller C; Mortier L; Murrell DF; Hamid O; Quevedo F; Schadendorf D; Hou J; Yue H, 2013, 'Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma (aBCC): 18-month update of the pivotal ERIVANCE BCC study', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 31 May - 4 June 2013
 
58 - Marchac D (1982)

Marchac D, Papadopoulos O, Duport G. Curative and aesthetic results of surgical treatment of 138 basal-cell carcinomas. J Dermatol Surg Oncol 1982 May;8(5):379-87. # http://www.ncbi.nlm.nih.gov/pubmed/7096764

 
59 - Marcil I (2000)

Marcil I, and Stern RS. 2000. Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis. Arch. Dermatol. 136 (12): 1524-1530. # http://www.ncbi.nlm.nih.gov/pubmed/11115165

 
60 - Marks R (2001)

Marks R, Gebauer K, Shumack S, Amies M, Bryden J, Fox TL, et al. Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial. J Am Acad Dermatol 2001 May;44(5):807-13. # http://www.ncbi.nlm.nih.gov/pubmed/11312429

 
61 - Marks R (2004)

Marks R, Owens M, Walters SA. Efficacy and safety of 5% imiquimod cream in treating patients with multiple superficial basal cell carcinomas. Arch Dermatol 2004 Oct;140(10):1284-5. # http://www.ncbi.nlm.nih.gov/pubmed/15492200

 
62 - McDaniel WE (1983)

McDaniel WE. Therapy for basal cell epitheliomas by curettage only. Further study. Arch Dermatol 1983 Nov;119(11):901-3. # http://www.ncbi.nlm.nih.gov/pubmed/6639109

 
63 - Miller BH (1997)

Miller BH, Shavin JS, Cognetta A, Taylor RJ, Salasche S, Korey A, et al. Nonsurgical treatment of basal cell carcinomas with intralesional 5-fluorouracil / epinephrine injectable gel. J Am Acad Dermatol 1997 Jan;36(1):72-7. # http://www.ncbi.nlm.nih.gov/pubmed/8996264

 
64 - Mohs F (1988)

Mohs F, Larson P, Iriondo M. Micrographic surgery for the microscopically controlled excision of carcinoma of the external ear. J Am Acad Dermatol 1988 Oct;19(4):729-37. # http://www.ncbi.nlm.nih.gov/pubmed/3053805

 
65 - Mohs FE (1986)

Mohs FE. Micrographic surgery for the microscopically controlled excision of eyelid cancers. Arch Ophthalmol 1986 Jun;104(6):901-9. # http://www.ncbi.nlm.nih.gov/pubmed/3718316

 
66 - Nikkels AF (2005)

Nikkels AF, Pierard-Franchimont C, Nikkels-Tassoudji N, Bourguignon R, Pierard GE. Photodynamic therapy and imiquimod immunotherapy for basal cell carcinomas. Acta Clin Belg 2005 Sep;60(5):227-34. # http://www.ncbi.nlm.nih.gov/pubmed/16398319

 
67 - Nordin P (1997)

Nordin P, Larko O, Stenquist B. Five-year results of curettage-cryosurgery of selected large primary basal cell carcinomas on the nose: an alternative treatment in a geographical area underserved by Mohs' surgery. Br J Dermatol 1997 Feb;136(2):180-3. # http://www.ncbi.nlm.nih.gov/pubmed/9068728

 
68 - Quirk C (2010)

Quirk C, Gebauer K, De'Ambrosis B, Slade HB, Meng TC. Sustained clearance of superficial basal cell carcinomas treated with imiquimod cream 5%: results of a prospective 5-year study. Cutis 2010 Jun;85(6):318-24. # http://www.ncbi.nlm.nih.gov/pubmed/20666194

 
69 - Reymann F (1979)

Reymann F. Treatment of basal cell carcinoma of the skin with 5-fluorouracil ointment. A 10-year follow-up study. Dermatologica 1979;158(5):368-72. # http://www.ncbi.nlm.nih.gov/pubmed/437226

 
70 - Rhodes LE (2007)

Rhodes LE, de Rie MA, Leifsdottir R, Yu RC, Bachmann I, Goulden V, et al. Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma. Arch Dermatol 2007 Sep;143 (9):1131-6. # http://www.ncbi.nlm.nih.gov/pubmed/17875873

 
71 - Richmond JD (1987)

Richmond JD, Davie RM. The significance of incomplete excision in patients with basal cell carcinoma. Br J Plast Surg 1987 Jan;40(1):63-7. # http://www.ncbi.nlm.nih.gov/pubmed/3814899

 
72 - Roozeboom MH (2012)

Roozeboom MH, Arits AH, Nelemans PJ, Kelleners-Smeets NW. Overall treatment success after treatment of primary superficial basal cell carcinoma: a systematic review and meta-analysis of randomized and nonrandomized trials. Br J Dermatol 2012 Oct;167(4):733-56. # http://www.ncbi.nlm.nih.gov/pubmed/22612571

 
73 - Rowe DE-a (1989)

Rowe DE, Carroll RJ, Day CL, Jr. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol 1989 Mar;15(3):315-28. [a] # http://www.ncbi.nlm.nih.gov/pubmed/2646336

 
74 - Rowe DE-b (1989)

Rowe DE, Carroll RJ, Day CL, Jr. Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma. J Dermatol Surg Oncol 1989 Apr;15(4):424-31.[b] # http://www.ncbi.nlm.nih.gov/pubmed/2925988

 
75 - Ruiz-Villaverde R (2009)

Ruiz-Villaverde R, Sanchez-Cano D, Burkhardt-Perez P. Superficial basal cell carcinoma treated with imiquimod 5% topical cream for a 4-week period: a case series. J Eur Acad Dermatol Venereol 2009 Jul;23(7):828-31. # http://www.ncbi.nlm.nih.gov/pubmed/19646136

 
76 - Sarma DP (1984)

Sarma DP, Griffing CC, Weilbaecher TG. Observations on the inadequately excised basal cell carcinomas. J Surg Oncol 1984 Feb;25(2):79-80. # http://www.ncbi.nlm.nih.gov/pubmed/6694405

 
77 - Schiessl C (2007)

Schiessl C, Wolber C, Tauber M, Offner F, Strohal R. Treatment of all basal cell carcinoma variants including large and high-risk lesions with 5% imiquimod cream: histological and clinical changes, outcome, and follow-up. J Drugs Dermatol 2007 May;6(5):507-13. # http://www.ncbi.nlm.nih.gov/pubmed/17679185

 
78 - Schleier P (2007)

Schleier P, Berndt A, Kolossa S Comparison of aminolevulinic acid (ALA)-thermogel-PDT with methyl-ALA-thermogel-PDT in basal cell carcinoma. Photodiagnosis and photodynamic therapy 2007 4:197-201. # http://www.ncbi.nlm.nih.gov/pubmed/25047438

 
79 - Schulze HJ (2005)

Schulze HJ, Cribier B, Requena L, Reifenberger J, Ferrandiz C, Garcia DA, et al. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe. Br J Dermatol 2005 May;152(5):939-47. # http://www.ncbi.nlm.nih.gov/pubmed/15888150

 
80 - Sekulic A (2012)

Sekulic A, Migden MR, Oro AE, Dirix L, Lewis KD, Hainsworth JD, et al. (2012) Efficacy and safety of vismodegib in advanced basal-cell carcinoma. The New England journal of medicine 366:2171-9. # http://www.ncbi.nlm.nih.gov/pubmed/22670903

 
81 - Shumack S (2004)

Shumack S, Gebauer K, Quirk C, Macdonald K, Walters SA, Owens M. 5% imiquimod cream for the treatment of large superficial basal cell carcinoma. Arch Dermatol 2004 Oct;140(10):1286-7. # http://www.ncbi.nlm.nih.gov/pubmed/15492202

 
82 - Shumack S (2002)

Shumack S, Robinson J, Kossard S, Golitz L, Greenway H, Schroeter A, et al. Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: comparison of dosing regimens. Arch Dermatol 2002 Sep;138(9):1165-71. # http://www.ncbi.nlm.nih.gov/pubmed/12224977

 
83 - Silverman MK-a (1992)

Silverman MK, Kopf AW, Bart RS, Grin CM, Levenstein MS. Recurrence rates of treated basal cell carcinomas. Part 3: Surgical excision. J Dermatol Surg Oncol 1992 Jun;18(6):471-6. # http://www.ncbi.nlm.nih.gov/pubmed/1592998

 
84 - Silverman MK-b (1992)

Silverman MK, Kopf AW, Gladstein AH, Bart RS, Grin CM, Levenstein MJ. Recurrence rates of treated basal cell carcinomas. Part 4: X-ray therapy. J Dermatol Surg Oncol 1992 Jul;18(7):549-54. # http://www.ncbi.nlm.nih.gov/pubmed/1624628

 
85 - Silverman MK (1991)

Silverman MK, Kopf AW, Grin CM, Bart RS, Levenstein MJ. Recurrence rates of treated basal cell carcinomas. Part 2: Curettage-electrodesiccation. J Dermatol Surg Oncol 1991 Sep;17(9):720-6. # http://www.ncbi.nlm.nih.gov/pubmed/1820764

 
86 - Smeets NW-a (2004)

Smeets NW, Krekels GA, Ostertag JU, Essers BA, Dirksen CD, Nieman FH, et al. Surgical excision vs Mohs' micrographic surgery for basal-cell carcinoma of the face: randomised controlled trial. Lancet 2004 Nov 13;364(9447):1766-72.[a] # http://www.ncbi.nlm.nih.gov/pubmed/15541449

 
87 - Smeets NW-b (2004)

Smeets NW, Kuijpers DI, Nelemans P, Ostertag JU, Verhaegh ME, Krekels GA, et al. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature. Br J Dermatol 2004 Jul;151(1):141-7.[b] # http://www.ncbi.nlm.nih.gov/pubmed/15270883

 
88 - SmPC Erivedge (2014)
 SmPC Erivedge, 22 mei 2014
 
89 - Soler AM (2000)

Soler AM, Angell-Petersen E, Warloe T, Tausjo J, Steen HB, Moan J, et al. Photodynamic therapy of superficial basal cell carcinoma with 5-aminolevulinic acid with dimethylsulfoxide and ethylendiaminetetraacetic acid: a comparison of two light sources. Photochem Photobiol 2000 Jun;71(6):724-9. # http://www.ncbi.nlm.nih.gov/pubmed/10857368

 
90 - Sterry W (2002)

Sterry W, Ruzicka T, Herrera E, Takwale A, Bichel J, Andres K, et al. Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: randomized studies comparing low-frequency dosing with and without occlusion. Br J Dermatol 2002 Dec;147(6):1227-36. # http://www.ncbi.nlm.nih.gov/pubmed/12452875

 
91 - Svanberg K (1994)

Svanberg K, Andersson T, Killander D, Wang I, Stenram U, Andersson-Engels S, et al. Photodynamic therapy of non-melanoma malignant tumours of the skin using topical delta-amino levulinic acid sensitization and laser irradiation. Br J Dermatol 1994 Jun;130(6):743-51. # http://www.ncbi.nlm.nih.gov/pubmed/8011500

 
92 - Szeimies RM (2008)

Szeimies RM, Ibbotson S, Murrell DF, Rubel D, Frambach Y, de BD, et al. A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8-20 mm), with a 12-month follow-up. J Eur Acad Dermatol Venereol 2008 Nov;22(11):1302-11. # http://www.ncbi.nlm.nih.gov/pubmed/18624836

 
93 - Tang JY (2012)

Tang JY, Mackay-Wiggan JM, Aszterbaum M, et al. Inhibiting the hedgehog pathway in patients with the basal-cell nevus syndrome. The New England journal of medicine 2012;366:2180-8. # http://www.ncbi.nlm.nih.gov/pubmed/22670904

 
94 - Telfer NR (2008)

Telfer NR, Colver GB, Morton CA. Guidelines for the management of basal cell carcinoma. Br J Dermatol 2008 Jul;159(1):35-48. # http://www.ncbi.nlm.nih.gov/pubmed/18593385

 
95 - Thissen MR (2000)

Thissen MR, Nieman FH, Ideler AH, Berretty PJ, Neumann HA. Cosmetic results of cryosurgery versus surgical excision for primary uncomplicated basal cell carcinomas of the head and neck. Dermatol Surg 2000 Aug;26(8):759-64. # http://www.ncbi.nlm.nih.gov/pubmed/10940063

 
96 - European Dermatology forum (2008)
Update of the Guideline on basal cell carcinoma 2008. European Dermatology forum.
 
97 - Vijlder de HC (2012)

Vijlder de HC, Sterenborg HJ, Neumann HA, Robinson DJ, de Haas ER. Light fractionation significantly improves the response of superficial basal cell carcinoma to aminolaevulinic acid photodynamic therapy: five-year follow-up of a randomized, prospective trial. Acta Derm Venereol 2012 Nov;92(6):641-7. # http://www.ncbi.nlm.nih.gov/pubmed/22964973

 
98 - Von Hoff DD (2009)

Von Hoff DD, LoRusso PM, Rudin CM, Reddy JC, Yauch RL, Tibes R, et al. (2009) Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. The New England journal of medicine 361:1164-72. # http://www.ncbi.nlm.nih.gov/pubmed/19726763

 
99 - Vries de E (2004)

Vries de E, Louwman M, Bastiaens M, de Gruijl F, and Coebergh JW. 2004. Rapid and continuous increases in incidence rates of basal cell carcinoma in the southeast Netherlands since 1973. J. Invest Dermatol. 123 (4): 634-638. # http://www.ncbi.nlm.nih.gov/pubmed/15373766

 
100 - Vries de E (2012)

Vries de E, Micallef R, Brewster DH, Gibbs JH, Flohil SC, Saksela O, Sankila R, Forrest AD, Trakatelli M, Coebergh JW, and Proby CM. 2012. Population-based estimates of the occurrence of multiple vs first primary basal cell carcinomas in 4 European regions. Arch. Dermatol. 148 (3): 347-354. # http://www.ncbi.nlm.nih.gov/pubmed/22431775

 
101 - Vries de E (2009)

Vries de E, Nijsten T, Louwman MW, and Coebergh JW. 2009. [Skin cancer epidemic in the Netherlands]. Ned. Tijdschr. Geneeskd. 153: A768. # http://www.ncbi.nlm.nih.gov/pubmed/20025791

 
102 - Vun Y (2006)

Vun Y, Siller G. Use of 5% imiquimod cream in the treatment of facial basal cell carcinoma: a 3-year retrospective follow-up study. Australas J Dermatol 2006 Aug;47(3):169-71. # http://www.ncbi.nlm.nih.gov/pubmed/16866996

 
103 - Wagner RF (1987)

Wagner RF, Jr., Cottel WI. Multifocal recurrent basal cell carcinoma following primary tumor treatment by electrodesiccation and curettage. J Am Acad Dermatol 1987 Dec;17(6):1047-9. # http://www.ncbi.nlm.nih.gov/pubmed/3429717

 
104 - Wang I (2001)

Wang I, Bendsoe N, Klinteberg CA, Enejder AM, Andersson-Engels S, Svanberg S, et al. Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial. Br J Dermatol 2001 Apr;144(4):832-40. # http://www.ncbi.nlm.nih.gov/pubmed/11298545

 
105 - Wennberg AM (1999)

Wennberg AM, Larko O, Stenquist B. Five-year results of Mohs' micrographic surgery for aggressive facial basal cell carcinoma in Sweden. Acta Derm Venereol 1999 Sep;79(5):370-2. # http://www.ncbi.nlm.nih.gov/pubmed/10494714

 
106 - Wennberg AM (1996)

Wennberg AM, Lindholm LE, Alpsten M, Larko O. Treatment of superficial basal cell carcinomas using topically applied delta-aminolaevulinic acid and a filtered xenon lamp. Arch Dermatol Res 1996 Sep;288(10):561-4. # http://www.ncbi.nlm.nih.gov/pubmed/8919036

 
107 - Wolf DJ (1987)

Wolf DJ, Zitelli JA. Surgical margins for basal cell carcinoma. Arch Dermatol 1987 Mar;123(3):340-4. # http://www.ncbi.nlm.nih.gov/pubmed/3813602

 
108 - Zacarian SA (1983)

Zacarian SA. Cryosurgery of cutaneous carcinomas. An 18-year study of 3,022 patients with 4,228 carcinomas. J Am Acad Dermatol 1983 Dec;9(6):947-56. # http://www.ncbi.nlm.nih.gov/pubmed/6643791

 
109 - De Silva SP (1985)

De Silva SP, Dellon AL. Recurrence rate of positive margin basal cell carcinoma: results of a five-year prospective study. J Surg Oncol 1985 Jan;28(1):72-4. # http://www.ncbi.nlm.nih.gov/pubmed/3968892

 
110 - Ahnlide I (2013)

Ahnlide I, Bjellerup M. Accuracy of clinical skin tumour diagnosis in a dermatological setting.Acta Derm Venereol. 2013 May;93(3):305-8

 
111 - Altamura D (2010)

Altamura D, Menzies SW, Argenziano G, Zalaudek I, Soyer HP, Sera F, Avramidis M, DeAmbrosis K, Fargnoli MC, Peris K. Dermatoscopy of basal cell carcinoma: morphologic variability of global and local features and accuracy of diagnosis. J Am Acad Dermatol. 2010 Jan;62(1):67-75

 
112 - Lallas A (2014)

Lallas A, Tzellos T, Kyrgidis A, Apalla Z, Zalaudek I, Karatolias A, Ferrara G, Piana S, Longo C, Moscarella E, Stratigos A, Argenziano G. Accuracy of dermoscopic criteria for discriminating superficial from other subtypes of basal cell carcinoma. J Am Acad Dermatol. 2014 Feb;70(2):303-11

 
113 - Ek EW (2005)

Ek EW, Giorlando F, Su SY, Dieu T. Clinical diagnosis of skin tumours: how good are we?

ANZ J Surg. 2005 Jun;75(6):415-20

 
115 - Har-Shai Y (2001)

Har-Shai Y, Hai N, Taran A, Mayblum S, Barak A, Tzur E, Schafer I, David R,David E, Linn S. Sensitivity and positive predictive values of presurgical clinical diagnosis of excised benign and malignant skin tumors: a prospective study of 835 lesions in 778 patients. Plast Reconstr Surg. 2001 Dec;108(7):1982-9

 
116 - Longo C (2014)

Longo C, Lallas A, Kyrgidis A, Rabinovitz H, Moscarella E, Ciardo S, Zalaudek I, Oliviero M, Losi A, Gonzalez S, Guitera P, Piana S, Argenziano G, Pellacani G. Classifying distinct basal cell carcinoma subtype by means of dermatoscopy and reflectance confocal microscopy. J Am Acad Dermatol. 2014 Oct;71(4):716-724

 
117 - Moehrle M (2007)

Moehrle M, Breuninger H, Röcken M. A confusing world: what to call histology of three-dimensional tumour margins? J Eur Acad Dermatol Venereol. 2007 May;21(5):591-5

 
118 - Moffatt CR (2006)

Moffatt CR, Green AC, Whiteman DC. Diagnostic accuracy in skin cancer clinics: the Australian experience. Int J Dermatol. 2006 Jun;45(6):656-6

 
119 - Peppelman M (2013)

Peppelman M, Wolberink EA, Blokx WA, van de Kerkhof PC, van Erp PE, Gerritsen MJ. In vivo diagnosis of basal cell carcinoma subtype by reflectance confocal microscopy. Dermatology. 2013;227(3):255-62.

 
120 - Roozeboom MH (2013)

Roozeboom MH, Mosterd K, Winnepenninckx VJ, Nelemans PJ, Kelleners-Smeets NW. Agreement between histological subtype on punch biopsy and surgical excision in primary basal cell carcinoma. J Eur Acad Dermatol Venereol 2013;27:894-8.

 
121 - Russell EB (1999)

Russell EB, Carrington PR, Smoller BR. Basal cell carcinoma: a comparison of shave biopsy versus punch biopsy techniques in subtype diagnosis. J Am Acad Dermatol 1999;41:69-71.

 
122 - Schwartzberg JB (2005)

Schwartzberg JB, Elgart GW, Romanelli P, Fangchao M, Federman DG, Kirsner RS.Accuracy and predictors of basal cell carcinoma diagnosis. Dermatol Surg. 2005 May;31(5):534-7

 
123 - Trakatelli M (2012)

Trakatelli M, Morton CA, Nagore E, Ulrich C, del Marmo V, Peris K, Seguin. European Dermatology Forum. Update of the Guideline on Basal Cell Carcinoma. 2012:48.

 
124 - Wolberink EA (2013)

Wolberink EA, Pasch MC, Zeiler M, van Erp PE, Gerritsen MJ. High discordance between punch biopsy and excision in establishing basal cell carcinoma subtype: analysis of 500 cases. J Eur Acad Dermatol Venereol 2013;27:985-9.

 
125 - Bath-Hextall F(1) (2014)

Bath-Hextall F(1), Ozolins M(2), Armstrong SJ(3), Colver GB(4), Perkins W(5),Miller PS(6), Williams HC(7); Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial. Lancet Oncol. 2014 Jan;15(1):96-105.

 
126 - Roozeboom MH(1) (2013)

Roozeboom MH(1), Aardoom MA, Nelemans PJ, Thissen MR, Kelleners-Smeets NW,Kuijpers DI, Mosterd K. Fractionated 5-aminolevulinic acid photodynamic therapy after partial debulking versus surgical excision for nodular basal cell carcinoma: a randomized controlled trial with at least 5-year follow-up. J Am Acad Dermatol. 2013 Aug;69(2):280-7

 
127 - Cosgarea R(1) (2013)

Cosgarea R(1), Susan M, Crisan M, Senila S. Photodynamic therapy using topical 5-aminolaevulinic acid vs. surgery for basal cell carcinoma. J Eur Acad Dermatol Venereol. 2013 Aug;27(8):980-4.

 
128 - Chren MM(1) (2011)

Chren MM(1), Torres JS, Stuart SE, Bertenthal D, Labrador RJ, Boscardin WJ. Recurrence after treatment of nonmelanoma skin cancer: a prospective cohort study. Arch Dermatol. 2011 May;147(5):540-6.

 
129 - Mosterd K(a) (2008)

Mosterd K(a), Thissen MR, Nelemans P, Kelleners-Smeets NW, Janssen RL, Broekhof KG, Neumann HA, Steijlen PM, Kuijpers DI.Fractionated 5-aminolaevulinic acid-photodynamic therapy vs. surgical excision in the treatment of nodular basal cell carcinoma: results of a randomized controlled trial. Br J Dermatol. 2008 Sep;159(4):864-70.

 
130 - Mosterd K (b) (2008)

Mosterd K (b), Krekels GA, Nieman FH, Ostertag JU, Essers BA, Dirksen CD, Steijlen PM, Vermeulen A, Neumann H, Kelleners-Smeets NW. Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up. Lancet Oncol. 2008 Dec;9(12):1149-56.

 
131 - Szeimies RM(1) (2008)

Szeimies RM(1), Ibbotson S, Murrell DF, Rubel D, Frambach Y, de Berker D, Dummer R, Kerrouche N, Villemagne H; Excilight Study Group. A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8-20 mm), with a 12-month follow-up. J Eur Acad Dermatol Venereol. 2008 Nov;22(11):1302-11.

 
132 - Kuijpers DI(1) (2007)

Kuijpers DI(1), Thissen MR, Berretty PJ, Ideler FH, Nelemans PJ, Neumann MH.Surgical excision versus curettage plus cryosurgery in the treatment of basal cell carcinoma. Dermatol Surg. 2007 May;33(5):579-87.

 
133 - Rhodes LE(1) (2004)

Rhodes LE(1), de Rie M, Enström Y, Groves R, Morken T, Goulden V, Wong GA, Grob JJ, Varma S, Wolf P. Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial. Arch Dermatol.2004 Jan;140(1):17-23.

 
134 - Rhodes LE1 (2007)

Rhodes LE1, de Rie MA, Leifsdottir R, Yu RC, Bachmann I, Goulden V, Wong GA, Richard MA, Anstey A, Wolf P. Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma. Arch Dermatol. 2007 Sep;143(9):1131-6.

 
135 - van Loo E (2014)

van Loo E, Mosterd K, Krekels GA, Roozeboom MH, Ostertag JU, Dirksen CD, Steijlen PM, Neumann HA, Nelemans PJ, Kelleners-Smeets NW. Surgical excision versus Mohs' micrographic surgery for basal cell carcinoma of the face: A randomised clinical trial with 10 year follow-up. Eur J Cancer. 2014 Nov;50(17):3011-20

 
136 - Bath-Hextall FJ (2007)

Bath-Hextall FJ, Perkins W, Bong J, Williams HC. Interventions for basal cell carcinoma of the skin. Cochrane Database Syst Rev. 2007 Jan 24;(1)

 
137 - Bentkover SH (2002)

Bentkover SH, Grande DM, Soto H, Kozlicak BA, Guillaume D, Girouard S. Excision of head and neck basal cell carcinoma with a rapid, cross-sectional, frozen-section technique. Arch Facial Plast Surg. 2002 Apr-Jun;4(2):114-9

 
138 - Chren MM (2011)

Chren MM, Torres JS, Stuart SE, Bertenthal D, Labrador RJ, Boscardin WJ. Recurrence after treatment of nonmelanoma skin cancer: a prospective cohort study. Arch Dermatol. 2011 May;147(5):540-6

 
139 - Essers BA (2006)

Essers BA, Dirksen CD, Nieman FH, Smeets NW, Krekels GA, Prins MH, Neumann HA. Cost-effectiveness of Mohs Micrographic Surgery vs Surgical Excision for Basal Cell Carcinoma of the Face. Arch Dermatol. 2006 Feb;142(2):187-94

 
140 - Gayre GS (2009)

Gayre GS, Hybarger CP, Mannor G, Meecham W, Delfanti JB, Mizono GS, Guerry TL, Chien JS, Sooy CD, Anooshian R, Simonds R, Pietila KA, Smith DW, Dayhoff DA, Engman E, Lacy J. Outcomes of excision of 1750 eyelid and periocular skin basal cell and squamous cell carcinomas by modified en face frozen section margin-controlled technique. Int Ophthalmol Clin. 2009 Fall;49(4):97-110)

 
141 - Leibovitch I (2005)

Leibovitch I, Huilgol SC, Selva D, Richards S, Paver R. Basal cell carcinoma treated with Mohs surgery in Australia II. Outcome at 5-year follow-up. J Am Acad Dermatol. 2005 Sep;53(3):452-7

 
142 - van Loo E (2014)

van Loo E, Mosterd K, Krekels GA, Roozeboom MH, Ostertag JU, Dirksen CD, Steijlen PM, Neumann HA, Nelemans PJ, Kelleners-Smeets NW. Surgical excision versus Mohs' micrographic surgery for basal cell carcinoma of the face: A randomised clinical trial with 10 year follow-up. Eur J Cancer. 2014 Nov;50(17):3011-20

 
143 - Mosterd K (2008)

Mosterd K, Krekels GA, Nieman FH, Ostertag JU, Essers BA, Dirksen CD, Steijlen PM, Vermeulen A, Neumann H, Kelleners-Smeets NW. Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up. Lancet Oncol. 2008 Dec;9(12):1149-56

 
144 - Muller FM (2009)

Muller FM, Dawe RS, Moseley H, Fleming CJ. Randomized comparison of Mohs micrographic surgery and surgical excision for small nodular basal cell carcinoma: tissue-sparing outcome. Dermatol Surg. 2009 Sep;35(9):1349-54

 
145 - Narayanan K (2014)

Narayanan K, Hadid OH, Barnes EA. Mohs micrographic surgery versus surgical excision for periocular basal cell carcinoma. Cochrane Database Syst Rev. 2014 Dec 12;12

 
146 - Rogers HW (2009)

Rogers HW, Coldiron BM. A relative value unit-based cost comparison of treatment modalities for nonmelanoma skin cancer: effect of the loss of the Mohs multiple surgery reduction exemption. J Am Acad Dermatol. 2009 Jul;61(1):96-103

 
147 - Smeets N (2004)

Smeets N, Krekels G, Ostertag J, Essers B, Dirksen C, Nieman F, Neumann M. Surgical excision versus Mohs micrographic surgery for basal cell carcinoma of the face; a prospective randomized trial. Lancet 2004; 364: 1766-72

 
148 - Smith-Zagone MJ (2005)

Smith-Zagone MJ, Schwartz MR. Frozen section of skin specimens. Arch Pathol Lab Med. 2005 Dec;129(12):1536-43.

 
149 - Wilson LS (2012)

Wilson LS, Pregenzer M, Basu R, Bertenthal D, Torres J, Asgari M, Chren MM. Fee comparisons of treatments for nonmelanoma skin cancer in a private practice academic setting. Dermatol Surg. 2012 Apr;38(4):570-84.

 
150 - Avril MF (1997)

Avril MF, Auperin A, Margulis A, Gerbaulet A, Duvillard P, Benhamou E, et al. Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomized study. Br J Cancer 1997;76(1):100-6

 
151 - Cognetta AB (2012)

Cognetta AB, Howard BM, Heaton HP, Stoddard ER, Hong HG, Green WH. Superficial x-ray in the treatment of basal and squamous cell carcinomas: a viable option in select patients. J Am Acad Dermatol 2012 Dec;67(6):1235-41

 
152 - Hall VL (1986)

Hall VL, Leppard BJ, McGill J, Kesseler ME, White JE, Goodwin P. Treatment of basal-cell carcinoma: comparison of radiotherapy and cryotherapy. Clin Radiol 1986 Jan;37(1):33-4

 
153 - Khan L (2012)

Khan L, Choo R, Breen D, Assaad D, Fialkov J, Antonyshyn O, et al. Recommendations for CTV margins in radiotherapy planning for non melanoma skin cancer. Radiother Oncol 2012 Aug;104(2):263-6

 
154 - Krema H (2013)

Krema H, Herrmann E, Albert-Green A, Payne D, Laperriere N, Chung C. Orthovoltage radiotherapy in the management of medial canthal basal cell carcinoma. Br J Ophthalmol 2013 Jun;97(6):730-4

 
155 - Landthaler M (1995)

Landthaler M, Hagspiel HJ, Braun-Falco O. Late irradiation damage to the skin caused by soft X-ray radiation therapy of cutaneous tumors. Arch Dermatol 1995 Feb;131(2):182-6

 
156 - Locke J (2001)

Locke J, Karimpour S, Young G, Lockett MA, Perez CA. Radiotherapy for epithelial skin cancer. Int J Radiat Oncol Biol Phys 2001 Nov 1;51(3):748-55

 
157 - Olschewski T (2006)

Olschewski T, Bajor K, Lang B, Lang E, Seegenschmiedt MH. [Radiotherapy of basal cell carcinoma of the face and head: Importance of low dose per fraction on long-term outcome]. J Dtsch Dermatol Ges 2006 Feb;4(2):124-30

 
158 - Petit JY (2000)

Petit JY, Avril MF, Margulis A, Chassagne D, Gerbaulet A, Duvillard P, et al. Evaluation of cosmetic results of a randomized trial comparing surgery and radiotherapy in the treatment of basal cell carcinoma of the face. Plast Reconstr Surg 2000 Jun;105(7):2544-51

 
159 - Rogers HW (2009)

Rogers HW, Coldiron BM. A relative value unit-based cost comparison of treatment modalities for nonmelanoma skin cancer: effect of the loss of the Mohs multiple surgery reduction exemption. J Am Acad Dermatol. 2009 Jul;61(1):96-103

 
160 - Silva JJ (1982)

Silva JJ, Tsang RW, Panzarella T, Levin W, Wells W. Results of radiotherapy for epithelial skin cancer of the pinna: the Princess Margaret Hospital experience, 1982-1993. Int J Radiat Oncol Biol Phys 2000 May 1;47(2):451-9

 
161 - Van Hezewijk M. (2010)

Van Hezewijk M., Creutzberg CL, Putter H, Chin A, Schneider I, Hoogeveen M, et al. Efficacy of a hypofractionated schedule in electron beam radiotherapy for epithelial skin cancer: Analysis of 434 cases. Radiother Oncol 2010 May;95(2):245-9

 
162 - Zagrodnik B (2003)

Zagrodnik B, Kempf W, Seifert B, Muller B, Burg G, Urosevic M, et al. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2. Cancer 2003 Dec 15;98(12):2708-14